Jogajog is a scoial media paltform.

Niranjan Karde agregó una foto Health
2026-07-24 20:38:41 -

Cluster Headache Syndrome Market Outlook 2036: Innovative CGRP Therapies and Neuromodulation Devices Drive Growth
The Cluster Headache Syndrome Market is expected to witness steady growth as the healthcare industry expands access to advanced neurological therapies and improves diagnosis of one of the most severe primary headache disorders. According to Future Market Insights (FMI), the market is projected to grow from USD 1.1 billion in 2026 to USD 1.9 billion by 2036, registering a 5.8% CAGR during the...

0 Commentarios 0 Acciones 477 Views 0 Vista previa

Please log in to like, share and comment!
Harshasharma Dbmr agregó una foto Other
2025-09-10 06:53:38 -

Internal Neuromodulation Devices Market: Insights and Competitive Analysis
"Executive Summary Internal Neuromodulation Devices Market Value, Size, Share and Projections CAGR Value The global internal neuromodulation devices market size was valued at USD 11.77 billion in 2024 and is expected to reach USD 36.26 billion by 2032, at a CAGR of 15.10% during the forecast period The top notch Internal Neuromodulation Devices...

0 Commentarios 0 Acciones 2K Views 0 Vista previa

Please log in to like, share and comment!
Henry Paul agregó una foto Other
2026-09-04 06:35:02 -

Neuromodulation Devices Market: Why Cybersecurity Is Becoming Critical for Connected Implants
The global neuromodulation devices market was valued at USD 6.4 billion in 2025 and is projected to grow from USD 7.0 billion in 2026 to USD 13.9 billion by 2033, expanding at a CAGR of 10.4%. North America leads with a 43.4% revenue share, spinal cord stimulators are the top-selling product, and Parkinson's disease is the largest application segment. Neuromodulation — the use...

0 Commentarios 0 Acciones 133 Views 0 Vista previa

Please log in to like, share and comment!
Anuj Mrfr agregó una foto Health
2025-12-14 17:13:15 -

The Vagus Nerve Stimulators (VNS) Segment: Extending Application Beyond Epilepsy in the Neuromodulation Devices Market
The Vagus Nerve Stimulators (VNS) segment is maintaining steady growth within the Neuromodulation Devices Market, primarily due to its long-standing efficacy in refractory epilepsy and its significant new approvals for treatment-resistant depression (TRD). VNS involves implanting a device that sends regular, mild electrical pulses to the left vagus nerve in the neck, which then modulates brain...

0 Commentarios 0 Acciones 955 Views 0 Vista previa

Please log in to like, share and comment!
Komal Galande agregó una foto Art
2026-08-12 03:27:54 -

Deep Brain Stimulation Systems Market Advances with Growing Demand for Neurological Therapies
According to the latest report published by Data Bridge Market Research, the Deep Brain Stimulation Systems Market CAGR Value This client-centric, leading edge and truthful Deep Brain Stimulation Systems Market report is generated with the experience of skilful, enthusiastic and innovative team. The numerical data, statistical data, facts and figures are represented very well...

0 Commentarios 0 Acciones 558 Views 0 Vista previa

Please log in to like, share and comment!
Komal Galande agregó una foto Causes
2026-08-13 03:41:33 -

Deep Brain Stimulation Systems Market Grows with Advances in Neuromodulation and Personalized Therapy
According to the latest report published by Data Bridge Market Research, the Deep Brain Stimulation Systems Market CAGR Value This client-centric, leading edge and truthful Deep Brain Stimulation Systems Market report is generated with the experience of skilful, enthusiastic and innovative team. The numerical data, statistical data, facts and figures are represented very well...

0 Commentarios 0 Acciones 504 Views 0 Vista previa

Please log in to like, share and comment!
Anuj Mrfr agregó una foto Health
2025-12-24 11:14:30 -

Technical Innovations in Spinal Cord Stimulation for Chronic Pain and Non-Opioid Alternatives within the Neuromodulation Devices Sector for Late 2025
As the global effort to reduce opioid reliance intensifies, Spinal Cord Stimulation (SCS) has emerged as a primary non-drug alternative for managing chronic neuropathic pain. In late 2025, technical innovations like "sub-perception" and "high-frequency" stimulation are allowing patients to experience profound pain relief without the tingling sensation—known as paresthesia—common in...

0 Commentarios 0 Acciones 987 Views 0 Vista previa

Please log in to like, share and comment!

Buscar

Promote Your Product

Publish Bulk Blog Posts
Boost Your Reach! 📝

Buscar

Promote Your Product

Publish Bulk Blog Posts Boost Your Reach! 📝

Publish Bulk Blog Posts
Boost Your Reach! 📝